Alto Neuroscience, Inc. · NYSE:ANRO
Commodore Capital LP reported a 9.80% stake in Alto Neuroscience, Inc. (Schedule 13G)
Event Oct 20, 2025 · Filed Oct 27, 2025
Commodore Capital LP reported a 9.80% stake in Alto Neuroscience, Inc., 3,190,267 shares, as a passive investor on Oct 20, 2025. Filed Oct 27, 2025 (Schedule 13G).
- Stake
- 9.80%
- Shares
- 3,190,267
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Commodore Capital LP | 9.80% | 3,190,267 |
| Commodore Capital Master LP | 9.80% | 3,190,267 |
| Robert Egen Atkinson | 9.80% | 3,190,267 |
| Michael Kramarz | 9.80% | 3,190,267 |
Source
Related
- Alto Neuroscience, Inc.
- Commodore Capital LP
- Alto Neuroscience, Inc. shareholders
- Schedule 13G/A · Commodore Capital LP · May 15, 2026
- Schedule 13G/A · Commodore Capital LP · Feb 17, 2026
- Form 4 · Smith Nicholas Conrad · Oct 5, 2026
- Form 4 · Smith Nicholas Conrad · Oct 1, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026